---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-009154"
form_type: "8-K"
ticker: "BICX"
cik: "0001443863"
company_name: "BioCorRx Inc."
filed_at: "2023-12-15T23:59:59+00:00"
generated_at: "2026-06-07T11:49:29.961598+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioCorRx raises $200K via note, warrant & inducement shares; note matures Sep 2024

## Summary
- Issued $220K principal note (8% OID) for $200K cash; unsecured, matures Sep 8, 2024.
- Six monthly amortization payments of $39,600 starting Apr 8, 2024; prepayable without penalty.
- Issued 4-year warrant for 200K shares at $2.00/share exercise price.
- Issued 24,000 restricted common shares as inducement.
- Securities issued in private placement under Section 4(a)(2) to a single accredited investor.

## SEC filing metadata
- accession: 0001477932-23-009154
- form_type: 8-K
- ticker: BICX
- cik: 0001443863
- company_name: BioCorRx Inc.
- filed_at: 2023-12-15T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1443863/000147793223009154/0001477932-23-009154-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1443863/000147793223009154/bicx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-009154
- JSON: https://secwatch.observer/filing/0001477932-23-009154.json
- Plain text: https://secwatch.observer/filing/0001477932-23-009154.txt

## Key facts
- Material Agreements
  BioCorRx Inc. entered into Securities Purchase Agreement with an accredited investor valued at $200,000 (effective 2023-12-08).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: an accredited investor
  - Value: $200,000
  - Effective: 2023-12-08
  source text: On December 8, 2023, BioCorRx Inc., a Nevada corporation (the “Company”), entered into a securities purchase agreement (the “SPA”) with an accredited investor (the “Investor”), whereby the Investor purchased from the Company, for a purchase price of $200,000 (the “Purchase Price”) (i) a promissory note of the Company in the original principal amount of $220,000.00 (the “Note”), (ii) a common stock purchase warrant for 200,000 shares (the “Warrant”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and (iii) 24,000 restricted shares of Common Stock (the “Inducement Shares”, and collectively with the Note and Warrant, the “Securities”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1443863/000147793223009154/0001477932-23-009154-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.